Cargando…
A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
BACKGROUND: Endometrial cancer (UCEC) is a complex malignant tumor characterized by both genetic level and clinical trial. Patients with UCEC exhibit the similar clinical features, however, they have distinct outcomes due to molecular heterogeneity. The aim of this study was to access the prognostic...
Autores principales: | Zhou, Meng, Zhang, Zhaoyue, Zhao, Hengqiang, Bao, Siqi, Sun, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756389/ https://www.ncbi.nlm.nih.gov/pubmed/29304762 http://dx.doi.org/10.1186/s12885-017-3983-0 |
Ejemplares similares
-
Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer
por: Zhou, Meng, et al.
Publicado: (2016) -
Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021) -
Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
por: Ding, Hongmei, et al.
Publicado: (2022) -
Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer
por: Zhou, Meng, et al.
Publicado: (2016) -
Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)